ArticleSurgical neurology international2024
Biological and hardware-related spinal cord stimulation complications and their management: A single-center retrospective analysis of the implantation of nonrechargeable implantable pulse generators in different pain conditions.
Article in Surgical neurology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Modulation of Surgical Site Infection Risk in Spinal and Thoracic Surgeries Through Operative Parameters: A Narrative Review.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We present our experience with spinal cord stimulation (SCS) for patients suffering from different pain conditions who subsequently developed hardware-related complications after SCS surgery. The SCS hardware-related complications may compromise the continuous SCS therapy due to partial or total hardware removal. Such situations should be avoided, and possible predisposing factors for their development should be minimized. The present study aimed to evaluate the frequency of hardware-related complications and their proper neurosurgical management. Methods: The study is designed as a retrospective analysis of all hardware-related complications of SCS procedures for pain patients who underwent the implantation of the nonrechargeable PrimeAdvanced Results: Among 20 patients, 8 (40%) patients were affected by hardware-related complications. The most common complications were skin erosion found in 5 patients (25%) and incorrect functioning of the implantable pulse generator (IPG) affecting 2 patients (10%). There were 1 case of an IPG migration (5%) and 1 hardware infection (5%) due to a staphylococcal wound. A total number of 16 revision surgeries were performed to manage all hardware-related complications in these patients adequately. Most of the patients (5 of them) were troubled by more than one hardware-related complication episode. Three patients had 3 revision surgeries, 2 patients had 2 revision surgeries, and 3 patients had 1 revision surgery. Among 8 patients with complications, 3 patients had no further continuation of SCS therapy due to hardware-related complications. Among these 3 patients who stopped their SCS therapy, 1 patient had 3 hardware-related episodes, and the remaining 2 patients were troubled by two hardware-related episodes before discontinuation of SCS therapy. Conclusion: Our results indicate that patients treated by the SCS technique are at higher risk for the development of skin-related complications, especially skin erosions and less common skin infections, notably in cases when large (high profile) IPGs are utilized. The use of smaller IPGs could reduce the number of these biological as well as hardware-related complications and associated revision surgeries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.